<div id="readability-page-1">Eikon Therapeutics, Inc (NASDAQ:EIKN) IPO will take place February, 05 on the NASDAQ exchange under the ticker EIKN. The company is offering shares at an expected price between $16.00 and $18.00 per share with an insider lock-up period of 180 days ending on August 04, 2026. See also: Benzinga IPO Calendar <h3>About Eikon Therapeutics, Inc</h3> Eikon Therapeutics, Inc is a late-stage clinical biopharmaceutical company dedicated to building a global, fully-integrated organization developing important, innovative medicines to address serious unmet medical needs. See also: Benzinga's Most Shorted Stocks This article was generated by Benzinga's automated content engine and reviewed by an editor.</div>

2 倍做多纳斯达克生物技术 ETF - ProShares

标普生物技术 ETF - SPDR

医药突破 ETF - ALPS

纽交所高增长板生物技术指数 ETF - First Trust

生物科技 ETF - VanEck Vectors

纳斯达克生物科技指数 ETF - iShares Nasdaq

阿尼卡医疗

NBSE.ESC

动态生物技术与基因组 ETF - Invesco

Eikon Therapeutics, Inc 将于 2026 年 2 月 5 日在纳斯达克上市，股票代码为 EIKN。预计每股价格在 16.00 美元至 18.00 美元之间，内部锁定期为 180 天，将于 2026 年 8 月 4 日结束。该公司专注于开发针对严重未满足医疗需求的创新药物

Preview: Eikon Therapeutics, Inc Set To IPO Tomorrow

fidelity

ESC NEUBASE THERAPEUTI

预览：Eikon Therapeutics, Inc 将于明日进行首次公开募股